Enteric fever in Cambodian children is dominated by multidrug-resistant H58 Salmonella enterica serovar Typhi with intermediate susceptibility to ciprofloxacin

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 106, Issue 12, 2012, Pages 718-724

  Emary, Kate ^a,b   Moore, Catrin E ^a,b,c   Chanpheaktra, Ngoun ^c   An, Khun Peng ^c   Chheng, Kheng ^c   Sona, Soeng ^c   Duy, Pham Thanh ^d   Nga, Tran Vu Thieu ^d   Wuthiekanun, Vanaporn ^a   Amornchai, Premjit ^a   Kumar, Varun ^c   Wijedoru, Lalith ^a,b   Stoesser, Nicole E ^a,b   Carter, Michael J ^a,b,e   Baker, Stephen ^b,d   Day, Nicholas P J ^a,b   Parry, Christopher M ^a,b,c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Angkor Hospital for Children   (Cambodia)

^d OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Antimicrobial resistance; Cambodia; Complications; Salmonella; Treatment; Typhoid

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; DNA TOPOISOMERASE (ATP HYDROLYSING); NALIDIXIC ACID; PHENYLALANINE; SERINE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BLOOD CULTURE; CAMBODIA; CHILD; CHILDHOOD DISEASE; CODON; FEMALE; GENOTYPE; HAPLOTYPE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; RELAPSE; SALMONELLA ENTERICA; SALMONELLA ENTERICA SEROVAR PARATYPHI A; SALMONELLA ENTERICA SEROVAR TYPHI; SALMONELLOSIS; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; TYPHOID FEVER;

SALMONELLA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI;

EID: 84869865604     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1016/j.trstmh.2012.08.007     Document Type: Article

References (30)

1. Coker R.J., Hunter B.M., Rudge J.W., Liverani M., Hanvoravongchai P. Emerging infectious diseases in southeast Asia: regional challenges to control. Lancet 2011, 377:599-609.
2. Emary K., Moore C., Parry C., Khun P.A., Ngoun C. Health in Southeast Asia. Lancet 2011, 377:1571.
3. Phetsouvanh R., Phongmany S., Soukaloun D., et al. Causes of community-acquired bacteraemia and patterns of antimicrobial resistance in Vientiane, Laos. Am J Trop Med Hyg 2006, 75:978-985.
4. Chierakul W., Rajanuwong A., Wuthiekanum V., et al. The changing pattern of bloodstream infections associated with the rise in HIV seroprevalence in northeastern Thailand. Trans R Soc Trop Med Hyg 2004, 98:678-686.
5. Nga T.V.T., Parry C.M., Le T., et al. The decline of typhoid and the rise of non-typhoid salmonellae and fungal infection in a changing HIV landscape: bloodstream infection trends over 15 years in southern Vietnam. Trans R Soc Trop Med 2012, 106:26-34.
6. Parry C.M., Hien T.T., Dougan G., White N.J., Farrar J.J. Typhoid Fever. New Engl J Med 2002, 347:1770-1782.
7. Chau T.T., Campbell J.I., Galindo C.M., et al. Antimicrobial drug resistance of Salmonella enterica serovar Typhi in Asia and molecular mechanism of reduced susceptibility to the fluoroquinolones. Antimicrob Agents Chemother 2007, 51:4315-4323.
8. Parry C.M., Vinh H., Chinh N.T., et al. The influence of reduced susceptibility to fluoroquinolones in Salmonella enterica serovar Typhi on the clinical response to ofloxacin therapy. PLoS Negl Trop Dis 2011, 5:e1163.
9. Cambodia Demographic and Health Survey 2010 2011, National Institute of Statistics, Directorate General for Health, and ICF Macro, National Institute of Statistics, Directorate General for Health, and ICF Macro, Phnom Penh, Cambodia and Calverton, MD.
10. Kasper M.R., Sokhal B., Blair P.J., Wierzba T.F., Putnam S.D. Emergence of multidrug-resistant Salmonella enterica serovar Typhi with reduced susceptibility to fluoroquinolones in Cambodia. Diagn Microbiol Infect Dis 2010, 66:207-209.
11. Wijedoru L., Kumar V., Chanpheaktra N., et al. Typhoid fever among hospitalised febrile children in Siem Reap, Cambodia. J Trop Pediatr 2012, 58:68-70.
12. Performance standards for antimicrobial sensitivity testing; Twenty-first Informational Supplement 2012, Clinical Laboratory Standards Institute, Clinical and Laboratory Standards Institute, Wayne, PA, CLSI Document M100-S22.
13. Holt K.E., Dolecek C., Chau T.T., et al. Temporal fluctuation of multidrug resistant Salmonella Typhi haplotypes in the Mekong river delta region of Vietnam. PLoS Negl Trop Dis 2011, 5:e929.
14. Kariuki S., Revathi G., Kiiru J., et al. Typhoid in Kenya is associated with a dominant multidrug-resistant Salmonella enterica serovar Typhi haplotype that is also widespread in Southeast Asia. J Clin Microbiol 2010, 48:2171-2176.
15. Dutta P., Mitra U., Dutta S., et al. Ceftriaxone therapy in ciprofloxacin treatment failure typhoid fever in children. Indian J Med Res 2001, 113:210-213.
16. Parry C.M., Ho V.A., Phuong L.T., et al. Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. Antimicrob Agents Chemother 2007, 51:819-825.
17. Dolecek C., Tran T.P., Nguyen N.R., et al. A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam. PLoS One 2008, 3:e2188.
18. Gaind R., Paglietti B., Murgia M., et al. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India. J Antimicrob Chemother 2006, 58:1139-1144.
19. Al Naiemi N., Zwart B., Rijnsburger M.C., et al. Extended-spectrum-beta-lactamase production in a Salmonella enterica serotype Typhi strain from the Philippines. J Clin Microbiol 2008, 46:2794-2795.
20. Phan M.D., Kidgell C., Nair S., et al. Variation in Salmonella enterica serovar Typhi IncH1 plasmids during the global spread of resistant typhoid fever. Antimicrob Agents Chemother 2009, 53:716-727.
21. Holt K.E., Phan M.D., Baker S., et al. Emergence of a globally dominant IncHI1 plasmid type associated with multiple drug resistant typhoid. PLoS Negl Trop Dis 2011, 5:e1245.
22. Mahle W.T., Levine M.M. Salmonella typhi infection in children younger than five years of age. Pediatr Infect Dis J 1993, 12:627-631.
23. Topley J.M. Mild typhoid fever in children. Arch Dis Child 1986, 61:164-167.
24. Butler T., Islam A., Kabir I., Jones P.K. Patterns of morbidity and mortality in typhoid fever dependent on age and gender: review of 552 hospitalised patients with diarrhoea. Rev Infect Dis 1991, 13:85-90.
25. Bhutta Z.A. Impact of age and drug resistance on mortality in typhoid fever. Arch Dis Child 1996, 75:214-217.
26. Walia M., Gaind R., Paul P., Mehta R., Aggarwal P., Kalaivani M. Age-related clinical and microbiological characteristics of enteric fever in India. Trans R Soc Trop Med Hyg 2006, 100:942-948.
27. Ochiai R.L., Wang X.Y., von Siedlein L., et al. Salmonella Paratyphi A rates, Asia. Emerg Infect Dis 2005, 11:1764-1766.
28. Graham S.M., Molyneux E.M., Walsh A.L., Cheesbough J.S., Molyneux M.E., Hart C.A. Nontyphoidal Salmonella infections of children in tropical Africa. Pediatr Infect Dis J 2000, 19:1189-1196.
29. Torrey S., Fleisher G., Jaffe D. Incidence of Salmonella bacteremia in infants with Salmonella gastroenteritis. J Pediatr 1986, 108:718-721.
30. WHO Typhoid vaccines: WHO position paper. Wkly Epidemiol Rec 2008, 83:49-60.